Jubilant Biosys Limited
Srividya Swaminathan is an accomplished professional with extensive experience in discovery biology and drug development. Currently serving as AVP Discovery Biology at Jubilant Biosys Limited since January 2019, Srividya has previously held prominent roles at AMRI as Senior Research Scientist II and Senior Research Scientist I, specializing in cell-based assessments and drug development programs across various disease areas, including oncology and neurodegenerative disorders. With a strong background in academic settings as a lecturer and supervisor at the National University of Singapore, Srividya has contributed to the training and mentorship of students and researchers. Educational qualifications include a Ph.D. in Life Sciences from Jawaharlal Nehru University and an MSc in Botany with specialization in Microbiology from Bangalore University.
This person is not in any offices
Jubilant Biosys Limited
1 followers
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.